Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03268850 · ClinicalTrials.gov registry record · NA
Living Kidney Donor Lost Wages Trial
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 453
- Enrollment target
NCT03268850: Completed NA study, sponsored by Beth Israel Deaconess Medical Center.
NCT03268850 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 453 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03268850, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 453 participants
- Enrollment target
Study Summary
This study aims to evaluate the effectiveness of offering reimbursement for living donor lost wages on the rate of live donor kidney transplantation.
Primary Outcome
LDKT rate in KT candidates compared to historical matched control group
Interventions
- OTHER Standard of Care
- BEHAVIORAL Wage Reimbursement A
- BEHAVIORAL Wage Reimbursement B
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 453 participants |
| Start Date | 2018-02-05 |
| Est. Completion | 2023-05-01 |
| Phase | NA |
What the finished NCT03268850 record still lists
NCT03268850 is an interventional study that assigns participants to a tested intervention. The registered 453 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower).
The record links to 0 conditions, and to 3 interventions - of which Standard of Care is the first listed.
NCT03268850 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03268850 about?
NCT03268850 is a clinical study titled "Living Kidney Donor Lost Wages Trial". This study aims to evaluate the effectiveness of offering reimbursement for living donor lost wages on the rate of live donor kidney transplantation.
What is the current status of trial NCT03268850?
This trial is currently completed. It is a NA study. The enrollment target is 453 participants. The study started on 2018-02-05. Estimated completion is 2023-05-01.
What interventions are being tested in trial NCT03268850?
The interventions under investigation include: Standard of Care (OTHER), Wage Reimbursement A (BEHAVIORAL), Wage Reimbursement B (BEHAVIORAL).
Who is sponsoring clinical trial NCT03268850?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03268850's enrollment target sits among peer trials
453 225th of 2000 higher than 1,776 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03460977 · 453 participants · Phase 1
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
- NCT04708171 · 453 participants
The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections
- NCT05489211 · 454 participants · Phase 2
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- NCT05655936 · 454 participants · NA
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI